Changing the course: the NHS's first treatment to delay type 1 diabetes
In this episode, we speak to Lucy Chambers, head of research impact and communications at Diabetes UK, and Amy Norman, whose daughter Imogen accessed teplizumab through a managed access programme after being identified through the ELSA screening study.